Clinical Trials Directory

Trials / Conditions / Metastatic Ovarian Cancer

Metastatic Ovarian Cancer

12 registered clinical trials studyying Metastatic Ovarian Cancer — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
NCT06533332
EtiraRx Australia Pty LtdPhase 1
RecruitingMeasuring Oncological Value of Exercise and Statin
NCT05796973
Tampere University HospitalPhase 3
TerminatedT-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian C
NCT04611126
Inge Marie SvanePhase 1 / Phase 2
WithdrawnSafety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Br
NCT03634150
Immune System Key LtdPhase 1 / Phase 2
TerminatedDurvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
NCT03277482
Dana-Farber Cancer InstitutePhase 1
UnknownAdoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in M
NCT03412526
Sheba Medical CenterPhase 2
CompletedTIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer
NCT03287674
Inge Marie SvanePhase 1 / Phase 2
UnknownEDMONd - Elemental Diet in Bowel Obstruction
NCT03150992
Royal Surrey County Hospital NHS Foundation TrustN/A
Completed[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging
NCT03242993
University of Lausanne HospitalsPhase 1
CompletedTIL Therapy for Metastatic Ovarian Cancer
NCT02482090
Inge Marie SvanePhase 1
CompletedPrognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer
NCT01768156
Institut du Cancer de Montpellier - Val d'AurelleN/A
RecruitingImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
NCT01174121
National Cancer Institute (NCI)Phase 2